Correlation Between CG Oncology, and Equillium
Can any of the company-specific risk be diversified away by investing in both CG Oncology, and Equillium at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CG Oncology, and Equillium into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CG Oncology, Common and Equillium, you can compare the effects of market volatilities on CG Oncology, and Equillium and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CG Oncology, with a short position of Equillium. Check out your portfolio center. Please also check ongoing floating volatility patterns of CG Oncology, and Equillium.
Diversification Opportunities for CG Oncology, and Equillium
0.27 | Correlation Coefficient |
Modest diversification
The 3 months correlation between CGON and Equillium is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding CG Oncology, Common and Equillium in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Equillium and CG Oncology, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CG Oncology, Common are associated (or correlated) with Equillium. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Equillium has no effect on the direction of CG Oncology, i.e., CG Oncology, and Equillium go up and down completely randomly.
Pair Corralation between CG Oncology, and Equillium
Given the investment horizon of 90 days CG Oncology, Common is expected to under-perform the Equillium. But the stock apears to be less risky and, when comparing its historical volatility, CG Oncology, Common is 1.71 times less risky than Equillium. The stock trades about 0.0 of its potential returns per unit of risk. The Equillium is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 90.00 in Equillium on September 12, 2024 and sell it today you would lose (20.00) from holding Equillium or give up 22.22% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 45.05% |
| Values | Daily Returns |
CG Oncology, Common vs. Equillium
Performance |
| Timeline |
| CG Oncology, Common |
| Equillium |
CG Oncology, and Equillium Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with CG Oncology, and Equillium
The main advantage of trading using opposite CG Oncology, and Equillium positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CG Oncology, position performs unexpectedly, Equillium can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Equillium will offset losses from the drop in Equillium's long position.| CG Oncology, vs. Equillium | CG Oncology, vs. DiaMedica Therapeutics | CG Oncology, vs. Valneva SE ADR | CG Oncology, vs. Vivani Medical |
| Equillium vs. Lyra Therapeutics | Equillium vs. Hookipa Pharma | Equillium vs. Jasper Therapeutics | Equillium vs. Cingulate Warrants |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |